tiprankstipranks
Trending News
More News >
Amrutanjan Health Care Limited (IN:AMRUTANJAN)
:AMRUTANJAN
India Market
Advertisement

Amrutanjan Health Care Limited (AMRUTANJAN) Financial Statements

Compare
0 Followers

Amrutanjan Health Care Limited Financial Overview

Amrutanjan Health Care Limited's market cap is currently ₹20.25B. The company's EPS TTM is ₹5.25; its P/E ratio is 39.40; and it has a dividend yield of 0.81%. Amrutanjan Health Care Limited is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 4.69B₹ 4.21B₹ 3.80B₹ 4.05B₹ 3.32B
Gross Profit₹ 2.46B₹ 2.09B₹ 1.98B₹ 2.25B₹ 1.91B
Operating Income₹ 1.31B₹ 621.03M₹ 418.55M₹ 798.41M₹ 717.93M
EBITDA₹ 758.79M₹ 681.60M₹ 590.79M₹ 946.99M₹ 861.66M
Net Income₹ 508.35M₹ 449.73M₹ 398.35M₹ 671.89M₹ 611.90M
Balance Sheet
Cash & Short-Term Investments₹ 831.56M₹ 2.10B₹ 1.93B₹ 2.01B₹ 1.75B
Total Assets₹ 4.21B₹ 3.67B₹ 3.62B₹ 3.50B₹ 2.74B
Total Debt₹ 20.78M₹ 17.28M₹ 9.09M₹ 8.80M₹ 13.42M
Net Debt₹ -810.78M₹ -240.35M₹ -39.94M₹ -826.05M₹ -1.29B
Total Liabilities₹ 947.73M₹ 783.82M₹ 713.21M₹ 847.44M₹ 587.06M
Stockholders' Equity₹ 3.27B₹ 2.88B₹ 2.91B₹ 2.65B₹ 2.16B
Cash Flow
Free Cash Flow₹ 153.46M₹ 211.93M₹ 102.91M₹ 287.32M₹ 878.02M
Operating Cash Flow₹ 508.99M₹ 279.11M₹ 192.18M₹ 521.96M₹ 897.63M
Investing Cash Flow₹ -309.66M₹ 191.65M₹ -24.75M₹ -362.12M₹ -877.61M
Financing Cash Flow₹ -134.90M₹ -482.66M₹ -140.26M₹ -167.02M₹ -63.17M
Currency in INR

Amrutanjan Health Care Limited Earnings and Revenue History

Amrutanjan Health Care Limited Debt to Assets

Amrutanjan Health Care Limited Cash Flow

Amrutanjan Health Care Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis